| Metric | Q3 2024 | Q2 2024 | Q3 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $6.8B | — | — | — | — |
| Op. Income | $175M | — | — | — | — |
| Gross Margin | 11.5% | — | — | — | — |
| Net Margin | 1.5% | — | — | — | — |
| EPS (Diluted) | $1.88 | — | — | — | — |
| Free Cash Flow | $62M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $6.8B |
| Cost of Revenue | $6.0B |
| GROSS PROFIT | $785M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $535M |
| SG&A Expenses | $535M |
| Other Expenses | $74M |
| Operating Expenses | $610M |
| Cost & Expenses | $6.6B |
| OPERATING INCOME | $175M |
| Interest Income | $0 |
| Interest Expense | $63M |
| Other Income/Expenses | -$59M |
| INCOME BEFORE TAX | $116M |
| Income Tax Expense | $15M |
| Net Income from Continuing Ops | $101M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $101M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $101M |
| D&A | $41M |
| EBIT | $179M |
| EBITDA | $220M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $6.8B |
| Cost of Revenue | $6.0B |
| GROSS PROFIT | $785M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $535M |
| SG&A Expenses | $535M |
| Other Expenses | $74M |
| Operating Expenses | $610M |
| Cost & Expenses | $6.6B |
| OPERATING INCOME | $175M |
| Interest Income | $0 |
| Interest Expense | $63M |
| Other Income/Expenses | -$59M |
| INCOME BEFORE TAX | $116M |
| Income Tax Expense | $15M |
| Net Income from Continuing Ops | $101M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $101M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $101M |
| D&A | $41M |
| EBIT | $179M |
| EBITDA | $220M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $101M |
| Depreciation & Amortization | $41M |
| Stock-Based Compensation | $8M |
| Deferred Income Tax | -$13M |
| Other Non-Cash Items | -$5M |
| Change in Working Capital | -$51M |
| OPERATING CASH FLOW | $81M |
| Capital Expenditure | -$19M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $11M |
| NET CASH FROM INVESTING | -$8M |
| Net Debt Issuance | -$69M |
| Common Stock Repurchased | -$51M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$314.0K |
| NET CASH FROM FINANCING | -$120M |
| FREE CASH FLOW | $62M |
| Net Change in Cash | $35M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $248M |
| Short-Term Investments | $0 |
| Net Receivables | $11.7B |
| Inventory | $4.5B |
| Other Current Assets | $1.0B |
| TOTAL CURRENT ASSETS | $17.5B |
| PP&E (Net) | $494M |
| Goodwill | $2.1B |
| Intangible Assets | $105M |
| Long-Term Investments | $62M |
| Tax Assets | $0 |
| Other Non-Current Assets | $663M |
| TOTAL NON-CURRENT ASSETS | $3.4B |
| TOTAL ASSETS | $20.9B |
| Account Payables | $9.4B |
| Short-Term Debt | $910M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $12.0B |
| Long-Term Debt | $2.4B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $564M |
| TOTAL NON-CURRENT LIABILITIES | $2.9B |
| TOTAL LIABILITIES | $14.9B |
| Common Stock | $58M |
| Additional Paid-In Capital | $583M |
| Retained Earnings | $6.1B |
| Treasury Stock | -$506M |
| Accum. Other Comp. Income | -$254M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $6.0B |
| Minority Interest | $73M |
| TOTAL EQUITY | $6.0B |
| TOTAL LIABILITIES & EQUITY | $20.9B |
| Total Debt | $3.3B |
| Net Debt | $3.0B |
